Pramiracetam is a synthetic nootropic compound belonging to the racetam family, first synthesized in the 1970s. It is a derivative of piracetam, with some structural modifications. Pramiracetam is primarily studied for its potential effects on cognitive functions, particularly memory formation and recall. Unlike some other nootropics, it is generally considered to have little to no sedative or stimulatory effects. It is available as a dietary supplement in some regions and is not currently approved by the U.S. Food and Drug Administration (FDA) as a drug for any medical condition, nor by the European Medicines Agency (EMA). Research into pramiracetam often focuses on its neuroprotective potential and its role in modulating specific neurotransmitter systems. Its development was initially influenced by a desire to find more potent or targeted cognitive enhancers compared to earlier racetam compounds.
Deep dive
Tap a section to expand.
Known interactions
Category rule: glp1 × supplement
Note
GLP-1 medications slow stomach emptying, changing how/when oral supplements absorb; rapid weight loss raises the importance of protein and micronutrients.
Time oral supplements when nausea is lowest; prioritize protein and micronutrients; discuss with your provider.
Category rule: supplement × medication
Note
Some supplements change how the body processes medications (absorption, liver enzymes, or additive effects).
Specific pairs are checked against a licensed drug database and shown with their own severity. Always confirm with your provider or pharmacist.
Frequently asked
Sources referenced
- PubChem
- Examine.com
- DrugBank
Stackwise compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician.
Related compounds
Others in the supplement category or studied for the same goals.
